Drugs / DTaP-Hep B-IPV vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01177722 Comparator | Aug 2010 → Oct 2011 | diphtheria, hepatitis B virus infection, pertussis, poliomyelitis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP-Hep B-IPV vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01177722 ↗ |
| Modality | Vaccine | “control vaccine, Infanrix hexa™” NCT01177722 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT01177722 ↗ |